EZH2 and neoplasm: Meanwhile, potent molecules selectively targeting EZH2 enzymatic activity have been discovered, including EPZ005687, EPZ-6438, EI1, UNC1999, and GSK126, which also exerts significant anti-tumor effects in distinct melanoma subsets (Volkel et al., 2015; Perotti et al., 2019).